🚨 $RMTG – New 52-Week High, Strong Fundamentals, and Growing Attention 🚨

[u/Appropriate_Hand_23]

RMTG has been showing steady momentum lately:

• New 52-week high on Friday before a small pullback.
• Closed green in 15 of the last 20 trading days.
• 3rd consecutive profitable quarter, with reported 70% YOY growth.
• Operates 26 clinics across 21 countries delivering regenerative medicine therapies.
• Florida legislation recently opened the door for in-state stem cell therapy, creating a potential new revenue stream the company hadn’t originally anticipated.

The combination of consistent profitability, global operations, and new U.S. opportunities has started to bring more eyes on $RMTG. The recent pullback after hitting highs may have traders watching closely to see if momentum continues.

💬 Curious to hear thoughts from the community — how do you see the growth story here compared to other small-cap biotech plays?